Transforming imaging data into actionable predictions
We design pioneering tools that unlock imaging data to improve patient outcomes.
Transforming imaging data into actionable predictions
We design pioneering tools that unlock imaging data to improve patient outcomes.
As value-based care models evolve,
there is a need to give
the right treatment for the right patient at the right time
From clinical research to personalized care
This is what we do. Healthcare providers, biopharma companies and RWE specialists partner with Quibim to power up the imaging part of their business, accelerating the arrival of precision medicine.
Life Sciences
Our unique multi-scale ways of seeing problems can guide decision-making at every stage in the drug development process. Quibim can reveal a full suite of novel biomarkers from existing and new patient datasets to enhance the power of multi-omics.
Providers
As a respected global leader in medical imaging analysis, our best-in-class software medical devices extract objective and highly accurate information versus traditional methods. Quibim uses the latest AI technology to improve patient outcomes and maximize drug programs.
Our Platform
We know real-world data. As your pioneering experts, we have advanced image harmonization techniques that make FAIR data analyzes a reality. Quibim has access to large databases and can analyse any image modality and any tissue from thousands of consecutive patients.
Imaging
partners futurists experts
Pioneering leaders
Who innovated the industry gold standard process for discovering imaging biomarkers.
Imaging biomarker panels
First company to bring the concept of panel to imaging, helping physicians to predict clinical endpoints and improve patient outcomes.
Top-tier biopharma
The best biopharma partners work with Quibim to maximize drug programs by the application of novel AI technologies.
300+ journal publications
Continually contributing to the generation of evidence with an extensive record of published research.
125+ sites
Work with Quibim globally.
50,000+ cancer patients registry
Leading member and software infrastructure of the biggest cancer imaging RWD registries.
One platform
Tissue-agnostic profiling across multiple indications in oncology, hematology, rheumatology and neuro.
10,000,000+ de-identified research imaging data
To power scientific discovery to improve patient outcomes.
Want to collaborate with us?
Leave your details and let’s build the future of healthcare together